WVE - Wave Life Sciences Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.29B
Enterprise Value 3
1.12B
Trailing P/E
N/A
Forward P/E 1
-8.60
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
74.95
Price/Book (mrq)
11.23
Enterprise Value/Revenue 3
65.19
Enterprise Value/EBITDA 6
-5.92

Trading Information

Stock Price History

Beta (5Y Monthly) 0.88
52-Week Change 3-21.92%
S&P500 52-Week Change 324.46%
52 Week High 350.23
52 Week Low 317.59
50-Day Moving Average 330.00
200-Day Moving Average 324.59

Share Statistics

Avg Vol (3 month) 3232.94k
Avg Vol (10 day) 3394.32k
Shares Outstanding 534.29M
Float 7.31M
% Held by Insiders 122.76%
% Held by Institutions 173.53%
Shares Short (Nov 29, 2019) 44.09M
Short Ratio (Nov 29, 2019) 418.2
Short % of Float (Nov 29, 2019) 416.92%
Short % of Shares Outstanding (Nov 29, 2019) 411.94%
Shares Short (prior month Oct 31, 2019) 43.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,143.56%

Management Effectiveness

Return on Assets (ttm)-36.61%
Return on Equity (ttm)-147.39%

Income Statement

Revenue (ttm)17.2M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)-34.80%
Gross Profit (ttm)-120.01M
EBITDA -189.43M
Net Income Avi to Common (ttm)-174.76M
Diluted EPS (ttm)-5.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)209.01M
Total Cash Per Share (mrq)6.09
Total Debt (mrq)33.3M
Total Debt/Equity (mrq)27.15
Current Ratio (mrq)1.88
Book Value Per Share (mrq)3.35

Cash Flow Statement

Operating Cash Flow (ttm)-159.81M
Levered Free Cash Flow (ttm)-116.06M